XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.300
-0.090 (-3.77%)
At close: Apr 28, 2026, 4:00 PM EDT
2.350
+0.050 (2.17%)
After-hours: Apr 28, 2026, 4:10 PM EDT
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
$96,800
Profits / Employee
-$630,800
Market Cap
5.76M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% |
| Dec 31, 2016 | 7 | 1 | 16.67% |
| Dec 31, 2015 | 6 | 1 | 20.00% |
| Dec 31, 2014 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| PMGC Holdings | 34 |
| Aptevo Therapeutics | 33 |
| Cardio Diagnostics Holdings | 17 |
| BioRestorative Therapies | 14 |
| Purple Biotech | 10 |
| Ernexa Therapeutics | 7 |
| Mustang Bio | 4 |
XTLB News
- 5 weeks ago - XTL Biopharmaceuticals (XTLB) Adjusts ADS to Ordinary Share Ratio - GuruFocus
- 5 weeks ago - XTL Biopharmaceuticals Announces ADS Ratio Change - GlobeNewsWire
- 2 months ago - XTL Biopharmaceuticals (XTLB) Faces Nasdaq Delisting Threat - GuruFocus
- 2 months ago - XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing - GlobeNewsWire
- 3 months ago - XTL Biopharmaceuticals Aims to Acquire Stake in NeuroNOS from Beyond Air (XAIR) - GuruFocus
- 3 months ago - XTL Update on Recent Developments - GlobeNewsWire
- 3 months ago - XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency - GlobeNewsWire
- 3 months ago - XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership - GlobeNewsWire